(87) investigated the role of a monoclonal antibody targeting humanized secreted frizzled-related protein 2, a protein that promotes angiogenesis and metastasis, in metastatic osteosarcoma resistance to PD-1/PD-L1 inhibitors, and its impact on T cells. The gene discussed is CD274; the disease is osteosarcoma.